CoChat

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments

Open access

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Abstract

Evidence-based pharmacological treatments are available for first-line treatment of major depressive disorder and for management of inadequate response, however, given the limitations of the evidence base, pharmacological management of MDD still depends on tailoring treatments to the patient.

Overview

Integrity signals

Registry

Crossref · 10.1177/0706743716659417

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 153 references

Research works printed but not linked: 1

  1. Rush AJ, Warden D, Wisniewski SR, . STAR*D: revising conventional wisdom. CNS Drugs. 2009;23:627–647.

Cited by

See all 1,181

Metadata

Authors
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., Uher, R., & the CANMAT Depression Work Group
Affiliations
  • University of Toronto (CA)
  • University of British Columbia (CA)
  • Department of Psychiatry, L’Université de Montréal, Montréal, Quebec
  • McGill University (CA)
  • University of Ottawa (CA)
  • Memorial University of Newfoundland (CA)
  • University of Calgary (CA)
  • Queen's University (CA)
  • Canadian Pharmacists Association (CA)
  • Dalhousie University (CA)
Venue
The Canadian Journal of Psychiatry
Published
2016-08-11
Volume
61
Issue
9
Pages
540-560
ISSN
  • 0706-7437 (ISSN-L)
  • 1497-0015
OpenAlex
W2478017657
Cited by
1,181
References
152
Citations by year
2026: 81 · 2025: 117 · 2024: 183 · 2023: 151 · 2022: 148 · 2021: 137 · 2020: 146 · 2019: 101 · 2018: 69 · 2017: 41 · 2016: 5
FWCI
7.86
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • The Canadian Journal of Psychiatry (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • International Society for Bipolar Disorders
  • Canadian Network for Mood and Anxiety Treatments
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, antidepressant treatment, second-generation antidepressants, antidepressant selection, drug-drug interactions, maintenance therapy, inadequate response to antidepressants, treatment-resistant depression, antidepressant switching, adjunctive therapy, measurement-based care, personalized treatment
MeSH terms
Antidepressive Agents, Canada, Major Depressive Disorder, Humans, Societies, Medical, Practice Guidelines as Topic, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. https://app.cochat.ai/papers/10.1177/0706743716659417
The paper
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., Uher, R., & the CANMAT Depression Work Group. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. The Canadian Journal of Psychiatry. https://doi.org/10.1177/0706743716659417

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.